FDG-PET in pediatric posterior fossa brain tumors.
Journal Article (Journal Article)
Seventeen pediatric patients with posterior fossa brain tumors were studied with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) and positron emission tomography (PET). The FDG uptake was ranked by two observers, and the results were correlated with tumor histology. Increased FDG uptake was associated with more malignant and aggressive tumor types. Heterogeneity of FDG uptake was associated with previous therapy, including radiation therapy and chemotherapy. 2-[18F]Fluoro-2-deoxy-D-glucose PET will likely be an important adjunct in the management of pediatric posterior fossa tumors, much as in adult patients with brain tumors.
Full Text
Duke Authors
Cited Authors
- Hoffman, JM; Hanson, MW; Friedman, HS; Hockenberger, BM; Oakes, WJ; Halperin, EC; Coleman, RE
Published Date
- January 1, 1992
Published In
Volume / Issue
- 16 / 1
Start / End Page
- 62 - 68
PubMed ID
- 1729308
Pubmed Central ID
- 1729308
International Standard Serial Number (ISSN)
- 0363-8715
Digital Object Identifier (DOI)
- 10.1097/00004728-199201000-00011
Language
- eng
Conference Location
- United States